PROS1 and COVID-19: Neutralizing antibodies, targeting the critical domain RBD of S-protein, prevent viral binding to the host cell surface and are considered important markers of protection from reinfection, both in SARS-CoV-2 animal model [55,56] and in COVID-19 patients [57,58].